Survival benefits of neoadjuvant chemotherapy in advanced pancreatic cancer with vascular resection: who benefits the most? A study on key predictive factors - Poll - MDSpire

Survival benefits of neoadjuvant chemotherapy in advanced pancreatic cancer with vascular resection: who benefits the most? A study on key predictive factors

  • By

  • Ting-Kai Liao

  • Wei-Hsun Lu

  • Ping-Jui Su

  • Chih-Jung Wang

  • Ying Jui Chao

  • Yan-Shen Shan

  • May 28, 2026

  • 0 min

Share

Original Source(s)

Survival benefits of neoadjuvant chemotherapy in advanced pancreatic cancer with vascular resection: who benefits the most? A study on key predictive factors

  • by Ting-Kai Liao, Wei-Hsun Lu, Ping-Jui Su, Chih-Jung Wang, Ying Jui Chao, Yan-Shen Shan

  • May 28, 2026

Related Content

Case Report: Conversion therapy for initially unresectable intrahepatic cholangiocarcinoma

A nomogram integrating DCE-MRI imaging features and clinicopathological parameters for predicting pathological complete response in HER2-positive breast cancer

Combined immunohistochemistry and FISH testing for diagnosing metaplastic thymoma: a case report of misdiagnosis as pulmonary mucinous epidermoid carcinoma